| Study Protocol Number | Study Title and Description |
|---|---|
| 25-0964 |
Exploring Remibrutinib as a Treatment Option for Chronic Spontaneous Urticaria in Adults
This study is comparing how well remibrutinib (Rhapsido) and dupilumab (Dupixent) work in adults with Chronic Spontaneous Urticaria (CSU). |